A comprehensive view of Obesity. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
US Patent Issued to Regeneron Pharmaceuticals on Sept. 17 for "Glucagon-like peptide 1 receptor agonists and uses thereof" (New York, Massachusetts Inventors)
Published:
September 18, 2024
by U.S. Fed News
|
U.S. FDA to introduce new food labeling rules for front of food and drink packages to combat obesity this fall; labels will flag products containing high levels of sodium, saturated fat, or added sugars
Published:
September 16, 2024
by The Washington Post (Print)
|
LG Chem Submits United States Patent Application for GLP-1 Receptor Agonist, Pharmaceutical Composition Comprising Same and Method for Preparing Same
Published:
September 16, 2024
by Pharmaceutical Patent News
|
Novo Nordisk highlights insulin initiation discussions at EASD 2024; company emphasizes link between obesity and 30% increase in overall mortality
Published:
September 13, 2024
by Industry Intelligence Inc.
|
ADA hosts CNS research symposium, offers advanced healthcare courses; Association launches Hispanic Heritage Month initiative to improve diabetes care for diverse populations
Published:
September 13, 2024
by Industry Intelligence Inc.
|
Ask us about our R&D/Patents market view